Cisplatin-resistant bladder carcinoma cells: Enhanced expression of metallothioneins

Urological Research

Volumn 27, Issue 3, 1999, Pages 157-163

  Siegsmund, Michael J ^a   Marx, Claudia ^a   Seemann, Othmar ^b   Schummer, Bernhard ^a   Steidler, Annette ^a   Toktomambetova, Lira ^a   Köhrmann, Kai Uwe ^a   Rassweiler, Jens ^b   Alken, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Urology   (Germany)

Author keywords

Capillary electrophoresis; Cisplatin resistance; Cross resistance; Metallothioneins; Methotrexate; Transitional cell carcinoma

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; METALLOTHIONEIN; METHOTREXATE; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CONCENTRATION RESPONSE; CROSS RESISTANCE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CADMIUM; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; GLUTATHIONE; HUMANS; METALLOTHIONEIN; METHOTREXATE; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0033035360     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050103     Document Type: Article

References (28)

1. Ahn H, Lee E, Kim K, Lee C (1994) Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J Urol 151:263
2. Ali-Osman F, Berger MS, Rairkar A, Stein DE (1994) Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy. J Cell Biochem 54:11
3. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin AR, Brown R (1996) Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56:1374
4. Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB, Williams RD (1994) Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. J Urol 152:2272
5. Bedford P, Shellard SA, Walker MC, Whelan RD, Masters JR, Hill BT (1987) Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin. Int J Cancer 40:681
6. Chao CC (1994) Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair. Mol Pharmacol 45:1137
7. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269:787
8. Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E (1994) Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J Clin Invest 94:703
9. Hunziker PE (1991) Purification of human isometallothioneins. Methods Enzymol 205:244
10. Jones SL, Hickson ID, Harris AL, Harnett PR (1994) Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma. Int J Cancer 59:388
11. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science 241:1813
12. Kondo Y, Kuo SM, Lazo JS (1994) Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum. J Pharmacol Exp Ther 270:1313
13. Kondo Y, Kuo SM, Watkins SC, Lazo JS (1995) Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res 55:474
14. Kotoh S, Naito S, Sakamoto N, Goto K, Kumazawa J (1994) Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. J Urol 152:1267
15. Larminat F, Bohr VA (1994) Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage. Nucleic Acids Res 22:3005
16. Moorehead RA, Armstrong SG, Rainbow AJ, Singh G (1996) Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*). Cancer Chemother Pharmacol 38:245
17. Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N (1993) The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP). Jpn J Cancer Res 84:83
18. Oldenburg J, Begg AC, van Vugt MJ, Ruevekamp M, Schornagel JH, Pinedo HM, Los G (1994) Characterization of resistance mechanisms to cisdiamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro. Cancer Res 54:487
19. Osmak M (1993) Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine. Neoplasma 40:97
20. Osmak M, Eljuga D (1993) The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin. Res Exp Med (Berl) 193:389
21. Saikawa Y, Kubota T, Kuo TH, Furukawa T, Tanino H, Watanabe M, Ishibiki K, Kitajima M (1993) Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine. Jpn J Cancer Res 84:787
22. Shellard SA, Fichtinger-Schepman AM, Lazo JS, Hill BT (1993) Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines. Anticancer Drugs 4:491
23. Shen DW, Akiyama S, Schoenlein P, Pastan I, Gottesman MM (1995) Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br J Cancer 71:676
24. Timmer-Bosscha H, Timmer A, Meijer C, de Vries EG, de Jong B, Oosterhuis JW, Mulder NH (1993) Cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res 53:5707
25. Wroblewski DH, Bhushan A, Xuan Y, Brinton BT, Tritton TR, Hacker MP (1996) Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline. Cancer Chemother Pharmacol 37:337
26. Yagoda A (1987) Chemotherapy of urothelial tract tumors. Cancer 60:574
27. Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS (1994) Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells. Mol Pharmacol 45:453
28. Zamble DB, Lippard SJ (1995) Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20:435